These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37285182)

  • 1. The Positive and Negative Predictive Value of Targeted Diagnostic Botox Injection in Nerve Decompression Migraine Surgery.
    ElHawary H; Kavanagh K; Janis JE
    Plast Reconstr Surg; 2024 May; 153(5):1133-1140. PubMed ID: 37285182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effectiveness of Peripheral Nerve Blocks for Diagnosis of Migraine Trigger Points.
    Rangwani SM; Hehr JC; Janis JE
    Plast Reconstr Surg; 2021 Dec; 148(6):992e-1000e. PubMed ID: 34847126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of outcome of surgical treatment of migraine headaches using a constellation of symptoms versus botulinum toxin type A to identify the trigger sites.
    Liu MT; Armijo BS; Guyuron B
    Plast Reconstr Surg; 2012 Feb; 129(2):413-419. PubMed ID: 21987048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of migraine headaches.
    Guyuron B; Tucker T; Davis J
    Plast Reconstr Surg; 2002 Jun; 109(7):2183-9. PubMed ID: 12045534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of surgical decompression to relieve migraine headaches.
    Poggi JT; Grizzell BE; Helmer SD
    Plast Reconstr Surg; 2008 Jul; 122(1):115-122. PubMed ID: 18594393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year outcome of surgical treatment of migraine headaches.
    Guyuron B; Kriegler JS; Davis J; Amini SB
    Plast Reconstr Surg; 2011 Feb; 127(2):603-608. PubMed ID: 20966820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive botulinum toxin type a response is a prognosticator for migraine surgery success.
    Lee M; Monson MA; Liu MT; Reed D; Guyuron B
    Plast Reconstr Surg; 2013 Apr; 131(4):751-757. PubMed ID: 23542247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.
    Binder WJ; Brin MF; Blitzer A; Schoenrock LD; Pogoda JM
    Otolaryngol Head Neck Surg; 2000 Dec; 123(6):669-76. PubMed ID: 11112955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection in the management of chronic migraine: the Saudi experience with a proposal for a new protocol.
    Algahtani H; Shirah B; Sukkar G; Bukhari H; Meftah I; Alhazmi A; Alshareef A; Algethami A; Alshanqiti A; Andeejani M
    Acta Neurol Belg; 2021 Dec; 121(6):1783-1787. PubMed ID: 33058053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the peripheral trigger point theory of migraine headaches: single-surgeon experience using botulinum toxin and surgical decompression.
    Janis JE; Dhanik A; Howard JH
    Plast Reconstr Surg; 2011 Jul; 128(1):123-131. PubMed ID: 21701329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botox treatment for migraine and chronic daily headache in adolescents.
    Chan VW; McCabe EJ; MacGregor DL
    J Neurosci Nurs; 2009 Oct; 41(5):235-43. PubMed ID: 19835236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Botulinum Toxin Type A in Medically Refractory Pediatric Patients With Chronic Daily Headaches and Its Impact on the Quality of Life.
    Akbar A; Ford J; Tripathi S
    J Child Neurol; 2024 Jan; 39(1-2):55-60. PubMed ID: 38351705
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted Peripheral Nerve-directed Onabotulinumtoxin A Injection for Effective Long-term Therapy for Migraine Headache.
    Janis JE; Barker JC; Palettas M
    Plast Reconstr Surg Glob Open; 2017 Mar; 5(3):e1270. PubMed ID: 28458982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current Means for Detection of Migraine Headache Trigger Sites.
    Guyuron B; Nahabet E; Khansa I; Reed D; Janis JE
    Plast Reconstr Surg; 2015 Oct; 136(4):860-867. PubMed ID: 26397259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled surgical trial of the treatment of migraine headaches.
    Guyuron B; Reed D; Kriegler JS; Davis J; Pashmini N; Amini S
    Plast Reconstr Surg; 2009 Aug; 124(2):461-468. PubMed ID: 19644260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Role of Fat Injection in the Treatment of Recalcitrant Migraine Headaches.
    Guyuron B; Pourtaheri N
    Plast Reconstr Surg; 2019 Mar; 143(3):877-885. PubMed ID: 30817663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
    Bernhard MK; Bertsche A; Syrbe S; Weise S; Merkenschlager A
    Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Long-Term, Targeted OnabotulinumtoxinA versus Peripheral Trigger Site Deactivation Surgery for the Treatment of Refractory Migraine Headaches.
    Schoenbrunner AR; Khansa I; Janis JE
    Plast Reconstr Surg; 2020 Feb; 145(2):401e-406e. PubMed ID: 31985655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trigger areas nerve decompression for refractory chronic migraine.
    Chen G; You H; Juha H; Lou B; Zhong Y; Lian X; Peng Z; Xu T; Yuan L; Woralux P; Hugo AB; Jianliang C
    Clin Neurol Neurosurg; 2021 Jul; 206():106699. PubMed ID: 34053808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of onabotulinum toxin A (Botox(®)) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study.
    Russo M; Manzoni GC; Taga A; Genovese A; Veronesi L; Pasquarella C; Sansebastiano GE; Torelli P
    Neurol Sci; 2016 Jul; 37(7):1127-31. PubMed ID: 27048312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.